GSK Sues Moderna for US Patent Infringement over COVID, RSV Vaccines

GlaxoSmithKline (GSK) sued Moderna in US federal court in Delaware, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster COVID-19 vaccine Spikevax and RSV shot mResvia.